#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary biliary cholangitis Myelofibrosis Neoplasm malignant Congenital megacolon Malformation venous Spinal cord injury cervical Medulloblastoma Scedosporium infection Usher's syndrome Arrhythmia Craniocerebral injury Drug eruption Arginase deficiency Thyroid cancer metastatic Ehlers-Danlos syndrome More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Treatment Proteus syndrome – Basic Information Mantle cell lymphoma refractory – Life with Disease Familial haemophagocytic lymphohistiocytosis – Trials in Disease Primary biliary cholangitis – Trials in Disease Malignant fibrous histiocytoma – Diagnostics Alagille syndrome – Treatment Haemolytic uraemic syndrome – Life with Disease Gaucher’s disease type III – Trials in Disease Haemophilia A with anti factor VIII – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iodine (123I) Iobenguane Doxazosin Mesilate Nebivolol Diacerein Flecainide Povetacicept Gadobenate Dimeglumine Disodium Folinate Tebentafusp Ethanol (96 Per Cent) Glycerol Phenylbutyrate Tetracosactide IBUZATRELVIR VHB937 BENZYDAMINE HYDROCHLORIDE GSK5460025A Anhydrous Caffeine Pristinamycin Temozolomide VTX-002 More therapies…

    Learn about Your Condition

    Type 1 diabetes mellitus Penile squamous cell carcinoma Small intestine carcinoma Lymphangiosarcoma Naevus flammeus Chondroplasty Haemorrhage Magnetic resonance imaging Pulmonary vascular disorder Urethral stenosis Mite allergy Medulloblastoma Macular telangiectasia Turner's syndrome Ophthalmoplegia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Cytisinicline and Nicotine Therapy for Patients with Nicotine Dependence and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nicotine dependence
    • Chronic kidney disease
    Investigated Drugs:
    • Cytisinicline
    • Nicotine
    Poland

  • Study Comparing Methylprednisolone and Methoxsalen for Treating Grade II Acute Graft-Versus-Host Disease in Adult Stem Cell Transplant Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute graft versus host disease in skin
    • Acute graft versus host disease
    Investigated Drugs:
    • Methoxsalen
    • Methylprednisolone Hemisuccinate
    • Posaconazole
    France

  • Study on Atorvastatin’s Effect on Preventing Atrial Fibrillation in Patients Undergoing Surgical Aortic Valve Replacement

    Recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Atorvastatin
    Denmark

  • Study on Early Use of Vasopressin and Norepinephrine for Patients with Septic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Argipressin
    Italy

  • Study on Corticosteroids and Rituximab to Prevent Worsening of Ocular Myasthenia Gravis in Newly Diagnosed Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Dexchlorpheniramine Maleate
    • Methylprednisolone Hemisuccinate
    • Azathioprine
    France

  • Study on Dexamfetamine for Adults with Amphetamine and Opioid Dependence Undergoing Opioid Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Norway
Previous Page
1 … 452 453 454 455 456 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!